LAZID is a broad-spectrum cephalosporin antibiotic containing Ceftazidime, which is highly effective in treating serious bacterial infections caused by gram-negative and gram-positive bacteria. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of harmful bacteria.
LAZID is available in different formulations, including Ceftazidime alone or in combination with Sulbactam or Tazobactam, which enhance its antibacterial action against resistant strains.
Indications
LAZID injections are prescribed for:
Respiratory Tract Infections – Treats pneumonia, bronchitis, and lung infections caused by susceptible bacteria.
Urinary Tract Infections (UTIs) – Helps in treating complicated and uncomplicated UTIs, including kidney infections.
Severe Skin & Soft Tissue Infections – Effective against cellulitis, abscesses, and infected wounds.
Intra-Abdominal Infections – Used for peritonitis, abdominal abscesses, and post-surgical infections.
Septicemia (Blood Infections) – Treats bacteremia and sepsis, especially in immunocompromised patients.
Meningitis – Used for bacterial meningitis caused by susceptible organisms.
Bone & Joint Infections – Prescribed for osteomyelitis and septic arthritis.
Neutropenic Fever – Often used as empiric therapy for febrile neutropenia in cancer patients.
The combinations with Tazobactam and Sulbactam offer extended antibacterial coverage, making them more effective against drug-resistant bacterial strains.
Dosage & Administration
The dosage of LAZID varies based on infection severity, patient’s age, weight, and kidney function.
Mild to Moderate Infections:
- Ceftazidime 500 mg – 1 gm every 8-12 hours via intravenous (IV) or intramuscular (IM) injection.
Severe Infections:
- Ceftazidime 2 gm every 8 hours via IV infusion.
LAZID-TP & LAZID-S 1500 (Combination Therapy):
- Given every 8-12 hours depending on the infection.
Pediatric Patients:
- 30-50 mg/kg/day, divided into 2-3 doses.
Neonates:
- 25-50 mg/kg/day, administered via IV.
Patients with Kidney Impairment:
- Dosage should be adjusted based on creatinine clearance levels.
Important: Always follow the doctor’s prescribed dosage and complete the full course of treatment to prevent antibiotic resistance.
Precautions & Warnings
Hypersensitivity Risk – Patients allergic to cephalosporins or penicillin should avoid LAZID.
Kidney Impairment – Dosage adjustments are necessary for patients with renal dysfunction.
Liver Disorders – Use with caution in patients with liver disease.
Pregnancy & Breastfeeding – Should be used only if clearly needed and prescribed by a doctor.
Superinfection Possibility – Prolonged use may lead to secondary infections or fungal overgrowth.
Interaction with Other Medications – May interact with aminoglycosides, diuretics, and anticoagulants.
Possible Side Effects of LAZID
LAZID is generally well-tolerated, but some patients may experience mild to moderate side effects, such as:
Injection Site Reactions (Pain, redness, or swelling)
Nausea, Vomiting, or Diarrhea
Headache & Dizziness
Skin Rash or Itching (Allergic Reactions)
Elevated Liver Enzymes (Monitor in long-term use)
Changes in Blood Counts (Rare cases of low platelet or white blood cell count)
Seek immediate medical attention if you experience severe allergic reactions, breathing difficulties, or persistent diarrhea.
Why Choose LAZID?
Broad-Spectrum Antibiotic – Treats a wide range of serious bacterial infections.
Effective Against Resistant Bacteria – Tazobactam & Sulbactam combinations enhance its antimicrobial coverage.
Fast-Acting IV & IM Formulations – Provides rapid relief and faster bacterial eradication.
Minimal Side Effects – Well-tolerated in most patients with rare adverse reactions.
Convenient Dosing Options – Available in multiple strengths for tailored treatment.
Always Consult a physician before taking any medication, and do not rely solely on this information for medical advice.
For more such product information and similar product category www.allengeindia.com/product-category/anti-bacterials
You can also contact us www.allengeindia.com/contact-us
